Which condition gets treated first: ADHD or substance use disorder?

Treat the most urgent risk first

The usual rule is simple: treat the condition that is most dangerous or destabilizing first. In real life, that often means starting with substance use disorder when there is intoxication, overdose risk, severe withdrawal, frequent blackouts, unsafe driving, unstable housing, or repeated crises. If those risks are present, they can make ADHD assessment less reliable and can make any treatment plan harder to follow.

That does not mean ADHD gets ignored. In co-occurring care, clinicians often support both at the same time, but the first moves focus on safety, withdrawal management if needed, and reducing immediate harm. CAMH notes that ADHD assessment in adults needs a careful history and attention to comorbid conditions, including substance use, because overlapping symptoms can complicate the picture.

If you need help now because of overdose risk, suicidal thoughts, or a substance-use crisis, call or text 9-8-8 in Canada or call 911.

Mild to moderate cases are often treated together

When substance use is present but not causing immediate medical or safety danger, clinicians often treat ADHD and substance use disorder together. That approach can work better than waiting for perfect abstinence, especially if untreated ADHD is feeding impulsivity, poor planning, missed appointments, or difficulty using coping skills.

Canadian ADHD guidance from CADDRA supports assessing the whole person, including coexisting conditions and functional impairment, then building an individualized plan. In practice, that can include counselling, relapse-prevention work, practical supports, and in some cases ADHD medication, with closer follow-up than usual.

Harm reduction is part of treatment

Good co-occurring care does not depend on all-or-nothing thinking. Harm reduction can be part of treatment from the start. That means reducing immediate harms even if someone is not fully abstinent, while still working toward recovery goals that fit the person’s situation.

• making a safety plan for overdose, cravings, and high-risk situations
• using counselling or addiction services alongside ADHD care
• setting smaller goals, such as fewer binges, fewer risky days, or better medication storage
• involving family or supports when appropriate, especially for teens
• tracking sleep, mood, use patterns, and triggers, because those can change attention symptoms

This matters because relapse risk can go both ways. Active substance use can disrupt ADHD treatment, but untreated ADHD can also make relapse more likely by worsening impulsivity, boredom intolerance, disorganization, and emotional reactivity. That is one reason many clinicians aim for coordinated care rather than a strict one-condition-only approach.

If you are trying to sort out whether attention problems are from ADHD, substance use, or both, see ADHD or substance use disorder: how do clinicians tell the difference in adults?.

Medication choices are more cautious

When ADHD and substance use disorder occur together, medication decisions are usually more cautious, not automatically off the table. The choice depends on what substance is involved, whether use is current or in remission, past misuse of prescriptions, the person’s stability, and how reliable follow-up is.

Clinicians may prefer options with lower misuse potential, may consider long-acting formulations rather than short-acting ones, may use non-medication supports first, and often monitor more closely. CADDRA’s guideline emphasizes individualized treatment planning and follow-up, rather than one rule for everyone.

• clear discussion of benefits, risks, and misuse concerns
• checking whether attention symptoms were present before substance use became a problem
• starting with one change at a time so effects are easier to interpret
• smaller prescription quantities or more frequent check-ins when risk is higher
• adding CBT or coaching strategies so medication is not the only support

A history of substance use does not automatically rule out ADHD medication, but it does change the risk-benefit review. More detail is here: Can you get ADHD medication if you have a history of substance use?.

What this looks like in Canadian care

In Canada, a proper ADHD assessment should not look at focus symptoms in isolation. CAMH’s adult ADHD assessment resource points clinicians to structured screening and assessment, including comorbidity review. CADDRA’s Canadian ADHD Practice Guidelines are a core professional reference used in Canadian practice, and they stress lifespan history, impairment, differential diagnosis, and ongoing monitoring.

For adults in the provinces Finding Focus serves, an adult ADHD assessment is a $399 one-time fee, done by video with a licensed clinician, using a structured process based on DSM-5-TR criteria and CADDRA-aligned practice. Results are often available within hours after the assessment, but timing can vary based on clinical needs and follow-up requirements. Not every assessment results in an ADHD diagnosis.

A free screener can help you decide whether an assessment may be worth discussing, but it is screening only and does not diagnose ADHD. If the person is a teen, Finding Focus offers assessment only for ages 12 to 17 in select provinces. For adults who want to find out whether they have ADHD, see /adult-adhd-clinic/ or the general overview at /adhd-testing-diagnosis/.